Skip to main content
. 2017 Apr 17;90(1073):20160403. doi: 10.1259/bjr.20160403

Table 2.

Baseline demographic and pathological tumour characteristics of the 163 patients with primary pancreatic ductal adenocarcinoma

Variable DPC4-expression (n = 75) DPC4-non-expression (n = 88) p-value
Age (years) 61.9 ± 9.5 61.8 ± 9.1 0.941
Sex (M : F) 43 : 32 49 : 39 0.832
Tumour location
 Head 48 (64.0%) 64 (72.7%) 0.231
 Body/tail 27 (36.0%) 24 (27.3%)
Initial presentation
 Symptomatica 48 (64.0%)a 63 (71.6%)a 0.300
 Incidental 27 (36.0%) 25 (28.4%)
Type of operation
 Total pancreatectomy 11 (14.7%) 13 (14.8%) 0.985
 Pancreaticoduodenectomy 46 (61.3%) 51 (58.0%) 0.661
 Distal pancreatectomy 18 (24.0%) 24 (27.3%) 0.634
Tumour grade
 Grade 1 11 (14.7%) 9 (10.2%) 0.569
 Grade 2 50 (66.7%) 65 (73.9%)
 Grade 3 14 (18.7%) 14 (15.9%)
T stage
 T1 5 (6.7%) 3 (3.4%) 0.179
 T2 4 (5.3%) 1 (1.1%)
 T3 66 (88.0%) 84 (95.5%)
Tumour stage (TNM)
 I 8 (10.7%) 3 (3.4%) 0.066
 II 67 (89.3%) 85 (96.6%)
Residual tumour
 R0 67 (89.3%) 75 (85.2%) 0.435
 R1 8 (10.7%) 13 (14.8%)
 R2 0 (0.0%) 0 (0.0%)

F, female; M, male.

Data are represented as mean ± standard deviation or number (percentage).

a

111 patients with initial symptoms, including 74 patients with pain, 30 patients with jaundice, 5 patients with indigestion and 2 patients with nausea and vomiting.